2010 – Present

  • Joseph, S., Quinn, K., Greenwood, A., Cope, A. V., McKay, P. F., Hayes, P. J., … Weber, J. (2017). A comparative phase I study of combination, homologous subtype-C DNA, MVA, and Env gp140 protein/adjuvant HIV vaccines in two immunization regimes. Frontiers in Immunology, 8(FEB). http://doi.org/10.3389/fimmu.2017.00149
  • Joachim, A., Bauer, A., Joseph, S., Geldmacher, C., Munseri, P. J., Aboud, S., … McCormack, S. (2016). Boosting with subtype C CN54rgp140 protein adjuvanted with glucopyranosyl lipid adjuvant after priming with HIV-DNA and HIV-MVA is safe and enhances immune responses: A phase I trial. PLoS ONE, 11(5). http://doi.org/10.1371/journal.pone.0155702
  • Herath, S., Le Heron, A., Colloca, S., Patterson, S., Tatoud, R., Weber, J., & Dickson, G. (2016). Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors. Vaccine, 34(37). http://doi.org/10.1016/j.vaccine.2016.07.028
  • Herath, S., Le Heron, A., Colloca, S., Bergin, P., Patterson, S., Weber, J., … Dickson, G. (2015). Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag-pol-nef antigen. Vaccine, 33(51). http://doi.org/10.1016/j.vaccine.2015.10.111
  • Knudsen, M. L., Ljungberg, K., Tatoud, R., Weber, J., Esteban, M., & Liljestr�m, P. (2015). Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 protein antigen. PLoS ONE, 10(2). http://doi.org/10.1371/journal.pone.0117042
  • McKay, P. F., Cope, A. V., Mann, J. F. S., Joseph, S., Esteban, M., Tatoud, R., … Shattock, R. J. (2014). Glucopyranosyl lipid a adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen. PLoS ONE, 9(1). http://doi.org/10.1371/journal.pone.0084707
  • Weber, J., & Tatoud, R. (2013). Testing times for HIV: Multiple strategies are needed to reach the HIV infected, undiagnosed population. BMJ (Online), 347(7925). http://doi.org/10.1136/bmj.f5556

2000 – 2010

  • Weber, J., Tatoud, R., & Fidler, S. (2010). Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: The strategic use of antiretroviral drugs to prevent HIV acquisition and transmission. AIDS, 24(SUPPL. 4). http://doi.org/10.1097/01.aids.0000390705.73759.2c
  • Fearnside, J. F., Dumas, M.-E., Rothwell, A. R., Wilder, S. P., Cloarec, O., Toye, A., … Gauguier, D. (2008). Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice. PLoS ONE, 3(2). http://doi.org/10.1371/journal.pone.0001668
  • Toye, A. A., Dumas, M. E., Blancher, C., Rothwell, A. R., Fearnside, J. F., Wilder, S. P., … Gauguier, D. (2007). Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia, 50(9). http://doi.org/10.1007/s00125-007-0738-5
  • Daly-Burns, B., Alam, T. N., Mackay, A., Clark, J., Shepherd, C. J., Rizzo, S., … Hudson, D. L. (2007). A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiation. Differentiation, 75(1). http://doi.org/10.1111/j.1432-0436.2006.00113.x
  • Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., … Nicholson, J. K. (2006). Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proceedings of the National Academy of Sciences of the United States of America, 103(33). http://doi.org/10.1073/pnas.0601056103
  • Stephen, R. L., Gustafsson, M. C. U., Jarvis, M., Tatoud, R., Marshall, B. R., Knight, D., … Palmer, C. N. A. (2004). Activation of Peroxisome Proliferator-Activated Receptor ? Stimulates the Proliferation of Human Breast and Prostate Cancer Cell Lines. Cancer Research, 64(9). http://doi.org/10.1158/0008-5472.CAN-03-2760
  • Arya, M., Patel, H. R. H., McGurk, C., Tatoud, R., Klocker, H., Masters, J., & Williamson, M. (2004). The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. Journal of Experimental Therapeutics and Oncology, 4(4).
  • Adamson, D. J. A., Frew, D., Tatoud, R., Roland Wolf, C., & Palmer, C. N. A. (2002). Diclofenac antagonizes peroxisome proliferator-activated receptor-? signaling. Molecular Pharmacology, 61(1). http://doi.org/10.1124/mol.61.1.7
  • Maillard, M., Cadot, B., Ball, R. Y., Sethia, K., Edwards, D. R., Perbal, B., & Tatoud, R. (2001). Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Journal of Clinical Pathology – Molecular Pathology, 54(4). http://doi.org/10.1136/mp.54.4.275

1990 – 2000

  • Tatoud, R. (1999). Insulin-like growth factor (IGF) network and prostate pathologies. Prostate Cancer and Prostatic Diseases, 2(2). http://doi.org/10.1038/sj.pcan.4500295
  • Sangrajrang, S., Denoulet, P., Millot, G., Tatoud, R., Podgorniak, M.-P., Tew, K. D., … Fellous, A. (1998). Estramustine resistance correlates with tau over-expression in human prostatic carcinoma cells. International Journal of Cancer, 77(4). http://doi.org/10.1002/(SICI)1097-0215(19980812)77:4<626::AID-IJC24>3.0.CO;2-2
  • Sangrajrang, S., Denoulet, P., Laing, N. M., Tatoud, R., Millot, G., Calvo, F., … Fellous, A. (1998). Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression. Biochemical Pharmacology, 55(3). http://doi.org/10.1016/S0006-2952(97)00472-3
  • Lebbe, C., Pellet, C., Tatoud, R., Agbalika, F., Dosquet, P., Desgrez, J. P., … Calvo, F. (1997). Absence of human herpesvirus 8 sequences in prostate specimens [14]. AIDS, 11(2).
  • De Cremoux, P., Ravery, V., Podgorniak, M. P., Chevillard, S., Toublanc, M., Thiounn, N., … Boccon-Gibod, L. (1997). Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy. European Urology, 32(1).
  • Lebbe, C., Tatoud, R., Morel, P., Calvo, F., Euvrard, S., Kanitakis, J., … Claudy, A. (1997). Human herpesvirus 8 sequences are not detected in epithelial tumors from patients receiving transplants. Archives of Dermatology, 133(1).
  • Prevost, G., Benamouzig, R., Veber, N., Fajac, A., Tatoud, R., Degeorges, A., & Eden, P. (1997). The somatostatin receptor subtype 2 is expressed in normal and tumoral human tissues70. Cancer Detection and Prevention, 21(1).
  • Le Moyec, L., Millot, G., Tatoud, R., Calvo, F., & Eugène, M. (1997). Lipid signals detected by NMR proton spectroscopy of whole cells are not correlated to lipid droplets evidenced by the Nile red staining. Cellular and Molecular Biology (Noisy-Le-Grand, France), 43(5).
  • Degeorges, A., Tatoud, R., Fauvel-Lafeve, F., Podgorniak, M.-P., Millot, G., De Cremoux, P., & Calvo, F. (1996). Stromal cells from human benign prostate hyperplasia produce A growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. International Journal of Cancer, 68(2). http://doi.org/10.1002/(SICI)1097-0215(19961009)68:2<207::AID-IJC12>3.0.CO;2-7
  • Le Moyec, L., Tatoud, R., Degeorges, A., Calabresse, C., Bauza, G., Eugène, M., & Calvo, F. (1996). Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line. Cancer Research, 56(15).
  • Tatoud, R., Degeorges, A., Prévost, G., Hoepffner, J.-L., Gauvillé, C., Millot, G., … Calvo, F. (1995). Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analog. Molecular and Cellular Endocrinology, 113(2). http://doi.org/10.1016/0303-7207(95)03630-P
  • Tatoud, R., Desgrandchamps, F., DeGeorges, A., & Thomas, F. (1993). Peptide growth factors in the prostate. Pathologie Biologie, 41(8).
  • Moyec, L. L., Tatoud, R., Eugene, M., Gauvillé, C., Primot, I., Charlemagne, D., & Calvo, F. (1992). Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines. British Journal of Cancer, 66(4). http://doi.org/10.1038/bjc.1992.327
  • Desgrandchamps, F., Tatoud, R., Cussenot, O., Teillac, P., & Le Duc, A. (1992). Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives. Progres En Urologie : Journal de l”Association Francaise d”urologie et de La Societe Francaise d”urologie, 2(6).
  • Le Moyec, L., Eugene, M., Gauville, C., Tatoud, R., Ouvrard, B. N., & Calvo, F. (1991). Lipid profiles of breast cancer cell lines: proton nuclear magnetic resonance spectroscopy. Comptes Rendus de l’Academie Des Sciences – Serie III, 312(1).